van Ruiten CC, van der Aart-van der Beek AB, IJzerman RG, Nieuwdorp M, et al. Effect of exenatide twice daily and dapagliflozin alone and in combination on markers of kidney function in obese patients with type 2 diabetes: a prespecified secondary analysis of a randomized controlled clinical trial. Diabetes Obes Metab 2021 Apr 28. doi: 10.1111/dom.14410.
PMID: 33908691